Cargando…

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth

Breast cancer progression and relapse is conceivably due to tumor initiating cells (TICs)/cancer stem cells. EMT (epithelial-mesenchymal-transition)-signaling regulates TICs’ turnover. However, the mechanisms associated with this episode are unclear. We show that, in triple-negative-breast cancer (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Amlan, Dhar, Kakali, Maity, Gargi, Sarkar, Sandipto, Ghosh, Arnab, Haque, Inamul, Dhar, Gopal, Banerjee, Snigdha, Banerjee, Sushanta K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430628/ https://www.ncbi.nlm.nih.gov/pubmed/28450698 http://dx.doi.org/10.1038/s41598-017-00916-z

Ejemplares similares

Pancreatic Tumor Cell Secreted CCN1/Cyr61 Promotes Endothelial cell migration and Aberrant Neovascularization
por: Maity, Gargi, et al.
Publicado: (2014)

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway
por: Haque, Inamul, et al.
Publicado: (2018)

CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression
por: Das, Amlan, et al.
Publicado: (2021)

CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen
por: Sarkar, S, et al.
Publicado: (2017)

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
por: Haque, Inamul, et al.
Publicado: (2011)

Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1
por: Dhar, Kakali, et al.
Publicado: (2010)

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019)

MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis
por: Ghosh, Arnab, et al.
Publicado: (2018)

The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression
por: Hawa, Zuhair, et al.
Publicado: (2016)

The role of CCN4/WISP-1 in the cancerous phenotype
por: Nivison, Mary P, et al.
Publicado: (2018)

The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells
por: Huang, Wei, et al.
Publicado: (2016)

Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft Tumors
por: De, Alok, et al.
Publicado: (2013)

WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells
por: Ferrand, Nathalie, et al.
Publicado: (2022)

CCN5/WISP2 and metabolic diseases
por: Grünberg, John R, et al.
Publicado: (2017)

Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines
por: Haque, Inamul, et al.
Publicado: (2020)

Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype
por: Ferrand, Nathalie, et al.
Publicado: (2014)

Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus
por: Maiese, Kenneth
Publicado: (2020)

CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells
por: Schütze, Norbert, et al.
Publicado: (2007)

WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone
por: Ono, Mitsuaki, et al.
Publicado: (2013)

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
por: Haque, Inamul, et al.
Publicado: (2017)

WISP-1/CCN4 Regulates Osteogenesis by Enhancing BMP-2 Activity
por: Ono, Mitsuaki, et al.
Publicado: (2011)

An Update to the WISP-1/CCN4 Role in Obesity, Insulin Resistance and Diabetes
por: Mirr, Małgorzata, et al.
Publicado: (2021)

CCN4/WISP1 Promotes Migration of Human Primary Osteoarthritic Chondrocytes
por: Timmermans, Ritchie G.M., et al.
Publicado: (2022)

Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells
por: Zhang, Yanhong, et al.
Publicado: (2005)

Normal growth and development in mice over-expressing the CCN family member WISP3
por: Nakamura, Yukio, et al.
Publicado: (2009)

Metabolic Effects of CCN5/WISP2 Gene Deficiency and Transgenic Overexpression in Mice
por: Alami, Tara, et al.
Publicado: (2021)

WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity
por: Ferrand, Nathalie, et al.
Publicado: (2017)

Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease
por: Maiese, Kenneth
Publicado: (2016)

Association of WISP1/CCN4 with Risk of Overweight and Gestational Diabetes Mellitus in Chinese Pregnant Women
por: Liu, Lei, et al.
Publicado: (2020)

On how CCN6 suppresses breast cancer growth and invasion
por: Huang, Wei, et al.
Publicado: (2011)

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer
por: Kleer, Celina G, et al.
Publicado: (2004)

Potential Role of CCN Proteins in Breast Cancer: Therapeutic Advances and Perspectives
por: Ahmed, Kazi Ahsan, et al.
Publicado: (2021)

Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer
por: Fuady, Jerry H, et al.
Publicado: (2014)

WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression
por: Chuang, Jing-Yuan, et al.
Publicado: (2015)

OTUB1 inhibits breast cancer by non‐canonically stabilizing CCN6
por: Zhao, Ying, et al.
Publicado: (2023)

SAT045 Sexually Dimorphic Effects Of CCN5/WISP2 Overexpression On HFD-STZ Induced Diabetes And Glucose Intolerance
por: Alami, Tara, et al.
Publicado: (2023)

Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells
por: Dhar, Madhu S, et al.
Publicado: (2006)

The emerging role of WISP proteins in tumorigenesis and cancer therapy
por: Liu, Yi, et al.
Publicado: (2019)

Vulvar Cancer with Cutaneous and Breast Metastases
por: Adhikari, Nawaraj, et al.
Publicado: (2021)

Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity
por: Pivovarova-Ramich, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1u8v7ijhgg0s907048omhuk8oo